Explore 3 Stock Ideas & Industry Insights Download Free Report

Announcements

Kyndryl Opens First European Cyber Defense Center in Paris

Kyndryl (NYSE:KD) issued a press release on October 27, 2026, announcing the opening of its first Cyber Defense Operations Center in Europe, located in Paris, France.

Aakashdeep | 27 October 2026

Lifeward Names Ronen Tsimerman as CFO, Effective Nov. 1

Lifeward Ltd. filed a Form 8-K on October 27, 2026, disclosing the appointment of Ronen Tsimerman, age 56, as Chief Financial Officer, principal financial officer, and principal accounting officer, effective November 1, 2026.

Aditi Sarkar | 27 October 2026

NewGenIvf Files $100M Shelf Registration on Nasdaq

NewGenIvf Group Limited filed a Form F-3 shelf registration statement with the U.S. Securities and Exchange Commission on October 27, 2026, seeking to offer up to US$100,000,000 in various securities including Class A ordinary shares, preferred shares, warrants, debt securities, subscription rights, and units.

Vinay Lochav | 27 October 2026

GeoVax Labs Signs $1M Revolving Loan With Bowery Consulting

GeoVax Labs, Inc. filed a Form 8-K on October 27, 2026, reporting that on October 25, 2026, it entered into a Revolving Loan Agreement with Bowery Consulting Group Inc., and that five directors resigned and three lender-designated directors were appointed effective October 23, 2026.

Vinay Lochav | 27 October 2026

CF Bankshares Q3 2026: Net Income $6.0M, NIM Rises to 2.96%

CF Bankshares Inc. (NASDAQ:CFBK) released its third-quarter 2026 earnings on October 27, 2026, reporting net income of $6.0 million and a net interest margin expansion to 2.96% for the three months ended September 30, 2026.

Anjali Anand | 27 October 2026

Pulmatrix Stockholders Approve Eos SENOLYTIX Merger at October 2026 Special Meeting

Pulmatrix, Inc. (NASDAQ:PULM) filed a Form 8-K on October 27, 2026, reporting the results of a special meeting of stockholders held on October 26, 2026, at which nine proposals related to a planned merger with Eos SENOLYTIX, Inc. were voted on and all approved.

Nitish Kishor | 27 October 2026

Atrium Therapeutics Doses First Patient in Corventis Trial

Atrium Therapeutics, Inc. filed a Form 8-K on October 27, 2026, announcing that the first patient has been dosed in the company's Phase 1/2 Corventis clinical trial evaluating ATR-1072 for the potential treatment of PRKAG2 syndrome.

Manish Choudhary | 27 October 2026

Caesarstone Hit With $46.5M Silicosis Verdict in California

Caesarstone Ltd. filed a Form 6-K on October 27, 2026, disclosing that a Los Angeles jury on October 26, 2026, found the company liable in a silicosis lawsuit and awarded the plaintiff approximately $67.3 million in total damages, with Caesarstone apportioned approximately $46.5 million …

Aakashdeep | 27 October 2026

Community Financial System Q3 2026 Earnings Results Filed

Community Financial System, Inc. filed a Form 8-K with the SEC on October 27, 2026, furnishing a press release announcing its results of operations for the third quarter ended September 30, 2026.

Manish Choudhary | 27 October 2026

AIAI Holdings Signs War Tech Consortium Services Deal with M42

AIAI Holdings Corporation filed a Form 8-K on October 27, 2026, disclosing that it entered into a Services Agreement with Messier 42 LLC on October 26, 2026, to jointly develop a War Tech Consortium focused on defense technology acquisition and sales.

Shwetambri Chauhan | 27 October 2026
Support

Hi! How can we help you today?

Loading…